Sanofi (SNYNF)
85.51
0.00 (0.00%)
USD |
OTCM |
Sep 15, 16:00
Sanofi Market Cap : 103.81B for Sept. 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 103.81B |
| September 14, 2026 | 103.81B |
| September 11, 2026 | 102.01B |
| September 10, 2026 | 106.01B |
| September 09, 2026 | 103.22B |
| September 08, 2026 | 105.75B |
| September 04, 2026 | 108.39B |
| September 03, 2026 | 108.39B |
| September 02, 2026 | 107.22B |
| September 01, 2026 | 109.39B |
| August 31, 2026 | 109.54B |
| August 28, 2026 | 110.61B |
| August 27, 2026 | 108.87B |
| August 26, 2026 | 108.87B |
| August 25, 2026 | 112.35B |
| August 24, 2026 | 112.35B |
| August 21, 2026 | 113.46B |
| August 20, 2026 | 109.92B |
| August 19, 2026 | 109.92B |
| August 18, 2026 | 109.28B |
| August 17, 2026 | 105.54B |
| August 14, 2026 | 106.96B |
| August 13, 2026 | 105.75B |
| August 12, 2026 | 105.75B |
| August 11, 2026 | 105.69B |
| Date | Value |
|---|---|
| August 10, 2026 | 104.23B |
| August 07, 2026 | 107.35B |
| August 06, 2026 | 105.99B |
| August 05, 2026 | 100.89B |
| August 04, 2026 | 100.89B |
| August 03, 2026 | 101.75B |
| July 31, 2026 | 101.82B |
| July 30, 2026 | 100.65B |
| July 29, 2026 | 110.25B |
| July 28, 2026 | 108.24B |
| July 27, 2026 | 107.45B |
| July 24, 2026 | 107.18B |
| July 23, 2026 | 107.18B |
| July 22, 2026 | 103.81B |
| July 21, 2026 | 106.84B |
| July 20, 2026 | 107.61B |
| July 17, 2026 | 105.63B |
| July 16, 2026 | 105.63B |
| July 15, 2026 | 105.63B |
| July 14, 2026 | 102.62B |
| July 13, 2026 | 104.97B |
| July 10, 2026 | 107.27B |
| July 09, 2026 | 106.17B |
| July 08, 2026 | 100.98B |
| July 07, 2026 | 103.50B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 502.00B |
| GSK Plc | 101.16B |
| Novartis AG | 253.75B |
| Pfizer Inc. | 157.01B |
| Roche Holding AG | 303.33B |
Market Cap Related Metrics
| PE Ratio | 22.02 |
| PS Ratio | 1.932 |
| PEG Ratio | 3.125 |
| Price to Book Value | 1.440 |
| Price to Free Cash Flow | 10.45 |
| Price | 85.51 |
| Earnings Yield | 4.54% |
| PEGY Ratio | 1.732 |
| Operating PE Ratio | 7.111 |
| Normalized PE Ratio | 12.44 |